Osel Devices Limited — PPTs, 27-05-2025: Investor Presentation

1. Financial Highlights:

Revenue rose 41% YoY to ₹186.6 Cr in FY25, with EBITDA up 47% to ₹33.5 Cr and margins improving to 18%. PAT grew 58% to ₹20 Cr, boosting PAT margin to 10.75%. H2FY25 maintained momentum—revenue at ₹99.2 Cr (+21%) and EBITDA margin above 20%. The balance sheet reflects healthy inventory and receivables growth, funded by increased short-term borrowings supporting working capital.

2. Strategic Initiatives & Growth Drivers:

Osel Devices aims for 25-30% CAGR in hearing aids and LED displays, riding on growing awareness and underpenetration in India’s hearing aid market plus expanding LED demand. The company is entering India’s ₹2.17 lakh Cr mobile/tablet market via an exclusive Philips brand license, managing manufacturing, marketing, and distribution. Growth is supported by innovation-driven R&D and capacity expansion.

3. Business Developments:

Secured exclusive Indian manufacturing and distribution rights for Philips mobiles and tablets, extending reach into consumer electronics. The model emphasizes strong post-sale service—warranty and annual maintenance contracts—creating recurring revenue streams that enhance margins.

4. Market Position & Competitive Advantage:

Integrated operations—from design to after-sales—allow 4-6% lower BOM costs, faster installations (7-30 days vs 45 days industry standard), and better margin capture. Strong certifications and government tender success reinforce credibility. In-house control over critical processes ensures consistent quality and customer satisfaction.

5. Investor Implications:

Double-digit revenue and profit growth, entry into a large mobile/tablet segment, and recurring revenue from services indicate positive growth potential. Investors should monitor Philips partnership scale-up and working capital execution amid inventory and receivables rise. The diversified portfolio across medical devices, LED, and mobile markets offers balanced growth opportunities.